Tag: Novo Nordisk

Thyroid Cancer Concerns Raised Regarding Active Ingredient in Popular Drugs Ozempic and Wegovy

The European Medicines Agency (EMA) has issued a drug safety signal (pdf) regarding the potential risk of thyroid cancer associated with certain classes of medications that include semaglutide, the active ingredient in the widely used drugs Ozempic, approved for Type 2 diabetes, and Wegovy, approved for obesity. The medications in question are glucagon-like peptide-1 (GLP-1) receptor…


Thousands of Australians Face Skyrocketing Costs as Labor Price Cut Force Lifesaving Drug From PBS

The federal government is under pressure from the Coalition after removing a key lifesaving drug from the pharmaceutical benefits scheme (PBS), sending its cost soaring for thousands of Australians. Fifteen thousand Australians, many whom are children, who rely on Novo Nordisk’s fast-acting insulin drug Fiasp to manage their Type 1 diabetes will now face skyrocketing…